Kingsview Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Kingsview Wealth Management, LLC

$4.45 Billion
Q3 2024

A detailed history of Kingsview Wealth Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 860 shares of REGN stock, worth $603,591. This represents 0.02% of its overall portfolio holdings.

Number of Shares

860

Previous 838 2.63%

Holding current value

$603,591

Previous $880,000 2.73%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $22,529 - $26,438	22 Added 2.63%	860 $904,000
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $30,028 - $36,420	34 Added 4.23%	838 $880,000
Q4 2023 Feb 08, 2024	BUY	$775.18 - $881.7 $7,751 - $8,817	10 Added 1.26%	804 $706,000
Q3 2023 Nov 07, 2023	BUY	$692.45 - $844.37 $74,784 - $91,191	108 Added 15.74%	794 $653,000
Q2 2023 Aug 10, 2023	SELL	$700.03 - $830.35 $700 - $830	-1 Reduced 0.15%	686 $492,000
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $14,290 - $17,366	-21 Reduced 2.97%	687 $564,000
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $80,471 - $87,368	-114 Reduced 13.87%	708 $510,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $52,231 - $65,913	91 Added 12.45%	822 $566,000
Q2 2022 Aug 16, 2022	BUY	$548.35 - $738.84 $21,934 - $29,553	40 Added 5.79%	731 $432,000
Q1 2022 Feb 08, 2024	SELL	$595.12 - $698.43 $56,536 - $66,350	-95 Reduced 11.82%	709 $495,000
Q4 2021 Feb 17, 2022	SELL	$543.48 - $670.97 $67,935 - $83,871	-125 Reduced 15.32%	691 $436,000
Q3 2021 Dec 03, 2021	BUY	$574.03 - $680.96 $66,013 - $78,310	115 Added 16.41%	816 $494,000
Q2 2021 Aug 17, 2021	BUY	$472.8 - $558.54 $23,640 - $27,927	50 Added 7.68%	701 $403,000
Q1 2021 May 24, 2021	BUY	$446.73 - $548.2 $10,274 - $12,608	23 Added 3.66%	651 $309,000
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $175,536 - $223,128	-367 Reduced 36.88%	628 $303,000
Q3 2020 Nov 19, 2020	SELL	$544.75 - $658.21 $13,618 - $16,455	-25 Reduced 2.45%	995 $557,000
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $30,585 - $39,923	-62 Reduced 5.73%	1,020 $636,000
Q1 2020 May 11, 2020	BUY	$336.18 - $494.43 $363,746 - $534,973	1,082 New	1,082 $528,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.

Account

Kingsview Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History